Sumitomo Pharma Co., Ltd. (4506.T)
JPY 695.0
(-0.71%)
JPY 695.0
(-0.71%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 751.37 Billion JPY | 3.22% |
| 2022 | 727.96 Billion JPY | 14.74% |
| 2021 | 634.43 Billion JPY | -3.87% |
| 2020 | 659.94 Billion JPY | 6.31% |
| 2019 | 620.77 Billion JPY | 84.44% |
| 2018 | 336.57 Billion JPY | -5.71% |
| 2017 | 356.96 Billion JPY | 7.1% |
| 2016 | 333.29 Billion JPY | 27.58% |
| 2015 | 261.24 Billion JPY | 0.26% |
| 2014 | 260.56 Billion JPY | 0.03% |
| 2013 | 260.49 Billion JPY | 0.98% |
| 2012 | 257.97 Billion JPY | 7.41% |
| 2011 | 240.18 Billion JPY | -9.67% |
| 2010 | 265.88 Billion JPY | -6.13% |
| 2009 | 283.26 Billion JPY | 324.05% |
| 2008 | 66.79 Billion JPY | -17.97% |
| 2007 | 81.43 Billion JPY | 6.41% |
| 2006 | 76.52 Billion JPY | -26.66% |
| 2005 | 104.33 Billion JPY | 58.09% |
| 2004 | 65.99 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 708 Billion JPY | -5.77% |
| 2024 Q2 | 685.52 Billion JPY | -3.18% |
| 2023 FY | 751.37 Billion JPY | 3.22% |
| 2023 Q2 | 736.81 Billion JPY | 1.81% |
| 2023 Q3 | 716.37 Billion JPY | -2.77% |
| 2023 Q4 | 751.37 Billion JPY | 4.88% |
| 2023 Q1 | 723.67 Billion JPY | -0.59% |
| 2022 Q2 | 689.34 Billion JPY | 1.6% |
| 2022 Q1 | 678.51 Billion JPY | 6.95% |
| 2022 FY | 727.96 Billion JPY | 14.74% |
| 2022 Q4 | 727.96 Billion JPY | 8.09% |
| 2022 Q3 | 673.49 Billion JPY | -2.3% |
| 2021 Q3 | 630.14 Billion JPY | 1.84% |
| 2021 Q4 | 634.43 Billion JPY | 0.68% |
| 2021 FY | 634.43 Billion JPY | -3.87% |
| 2021 Q1 | 638.01 Billion JPY | -3.32% |
| 2021 Q2 | 618.74 Billion JPY | -3.02% |
| 2020 Q3 | 670.26 Billion JPY | 11.25% |
| 2020 Q2 | 602.49 Billion JPY | 0.52% |
| 2020 FY | 659.94 Billion JPY | 6.31% |
| 2020 Q1 | 599.39 Billion JPY | -3.44% |
| 2020 Q4 | 659.94 Billion JPY | -1.54% |
| 2019 FY | 620.77 Billion JPY | 84.44% |
| 2019 Q4 | 620.77 Billion JPY | 4.72% |
| 2019 Q3 | 592.8 Billion JPY | 102.06% |
| 2019 Q2 | 293.37 Billion JPY | -7.93% |
| 2019 Q1 | 318.62 Billion JPY | -5.33% |
| 2018 Q1 | 352.42 Billion JPY | -1.27% |
| 2018 Q4 | 336.57 Billion JPY | 1.36% |
| 2018 Q3 | 332.06 Billion JPY | -3.84% |
| 2018 FY | 336.57 Billion JPY | -5.71% |
| 2018 Q2 | 345.33 Billion JPY | -2.01% |
| 2017 Q2 | 332.52 Billion JPY | -1.12% |
| 2017 Q1 | 336.27 Billion JPY | 0.9% |
| 2017 FY | 356.96 Billion JPY | 7.1% |
| 2017 Q4 | 356.96 Billion JPY | 9.77% |
| 2017 Q3 | 325.18 Billion JPY | -2.21% |
| 2016 Q4 | 333.29 Billion JPY | 20.22% |
| 2016 Q1 | 232.25 Billion JPY | -11.1% |
| 2016 Q2 | 222.3 Billion JPY | -4.28% |
| 2016 FY | 333.29 Billion JPY | 27.58% |
| 2016 Q3 | 277.23 Billion JPY | 24.71% |
| 2015 Q2 | 270.44 Billion JPY | 0.5% |
| 2015 FY | 261.24 Billion JPY | 0.26% |
| 2015 Q3 | 288.53 Billion JPY | 6.69% |
| 2015 Q4 | 261.24 Billion JPY | -9.46% |
| 2015 Q1 | 269.11 Billion JPY | 3.28% |
| 2014 Q3 | 264.62 Billion JPY | 5.52% |
| 2014 Q2 | 250.76 Billion JPY | 3.52% |
| 2014 Q1 | 242.23 Billion JPY | -7.01% |
| 2014 FY | 260.56 Billion JPY | 0.03% |
| 2014 Q4 | 260.56 Billion JPY | -1.53% |
| 2013 Q1 | 259.26 Billion JPY | 0.5% |
| 2013 Q3 | 255.48 Billion JPY | -0.64% |
| 2013 FY | 260.49 Billion JPY | 0.98% |
| 2013 Q4 | 260.49 Billion JPY | 1.96% |
| 2013 Q2 | 257.13 Billion JPY | -0.82% |
| 2012 FY | 257.97 Billion JPY | 7.41% |
| 2012 Q2 | 250.56 Billion JPY | -0.15% |
| 2012 Q3 | 246.09 Billion JPY | -1.78% |
| 2012 Q1 | 250.94 Billion JPY | 4.48% |
| 2012 Q4 | 257.97 Billion JPY | 4.83% |
| 2011 FY | 240.18 Billion JPY | -9.67% |
| 2011 Q1 | 249.51 Billion JPY | -6.16% |
| 2011 Q3 | 238.18 Billion JPY | 0.16% |
| 2011 Q2 | 237.8 Billion JPY | -4.69% |
| 2011 Q4 | 240.18 Billion JPY | 0.84% |
| 2010 Q3 | 259.8 Billion JPY | -1.83% |
| 2010 Q4 | 265.88 Billion JPY | 2.34% |
| 2010 Q2 | 264.65 Billion JPY | -4.01% |
| 2010 Q1 | 275.72 Billion JPY | -2.66% |
| 2010 FY | 265.88 Billion JPY | -6.13% |
| 2009 Q3 | 328.54 Billion JPY | 438.6% |
| 2009 FY | 283.26 Billion JPY | 324.05% |
| 2009 Q4 | 283.26 Billion JPY | -13.78% |
| 2009 Q2 | 61 Billion JPY | 0.0% |
| 2008 Q4 | 66.79 Billion JPY | 0.0% |
| 2008 FY | 66.79 Billion JPY | -17.97% |
| 2007 FY | 81.43 Billion JPY | 6.41% |
| 2006 FY | 76.52 Billion JPY | -26.66% |
| 2005 FY | 104.33 Billion JPY | 58.09% |
| 2004 FY | 65.99 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -2906.923% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 90.41% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | -357.166% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -22031.801% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -1652.753% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -2596.368% |
| Eisai Co., Ltd. | 494.82 Billion JPY | -51.846% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -14808.135% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -1117.898% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -2336.981% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -1788.149% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -2317.224% |
| Tsumura & Co. | 132.88 Billion JPY | -465.424% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -1788.291% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -5550.673% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | -173.466% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -1601.549% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -962.686% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -1502.307% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -10629.259% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -2853.615% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -9128.169% |
| MedRx Co., Ltd | 129 Million JPY | -582357.364% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -22859.877% |
| Solasia Pharma K.K. | 673 Million JPY | -111544.874% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -116300.698% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -2294.347% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | -358.169% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -74194.5% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | -43.395% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -10707.442% |